Literature DB >> 5171936

Further studies on the mode of action of amantadine.

U Strömberg, T H Svensson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5171936     DOI: 10.1111/j.1600-0773.1971.tb00646.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


× No keyword cloud information.
  11 in total

Review 1.  Current drug therapy for Parkinson's disease. A review.

Authors:  R J Coleman
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

2.  Co-administration of memantine and amantadine with sub/suprathreshold doses of L-Dopa restores motor behaviour of MPTP-treated mice.

Authors:  A Fredriksson; W Danysz; G Quack; T Archer
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

Review 3.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

Review 4.  Tremor-predominant Parkinson's disease. Approaches to treatment.

Authors:  J Marjama-Lyons; W Koller
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

5.  On the effect of amantadine on ATP content and ATPase activity in brain and blood of rats.

Authors:  V A Velkov
Journal:  Experientia       Date:  1974-04-15

6.  Amantadine actions on acetylcholine and GABA in striatum and substantia nigra of rat in relation to behavioral changes.

Authors:  I J Bak; R Hassler; J S Kim; K Kataoka
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

7.  Responses of neurones in the cerebral cortex and caudate nucleus to amantadine, amphetamine and dopamine.

Authors:  T W Stone
Journal:  Br J Pharmacol       Date:  1976-01       Impact factor: 8.739

8.  In vitro studies on the possible effects of 1-aminoadamantanes on the serotonergic system in M. Parkinson.

Authors:  W Wesemann; G Dette-Wildenhahn; H Fellehner
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

Review 9.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

10.  Evidence for presynaptic antagonism by amantadine of indirectly acting central stimulants.

Authors:  M K Menon; C A Vivonia; V G Haddox
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.